Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA

Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA

Introduction: Adding LAMA to LABA/ICS is recommended to improve control in patients with persistent asthma. Methods: This observational, retrospective, before-and-after study considered patients diagnosed with asthma who started LABA/ICS + LAMA treatment (triple therapy, TT) between 1 January 2017 a...

Full description

Bibliographic Details
Main Authors:	Vicente Plaza, Javier Domínguez-Ortega, Diego González-Segura Alsina, Daniele Lo Re, Antoni Sicras-Mainar
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Pharmaceuticals
Subjects:	dual therapy triple therapy asthma long-acting muscarinic antagonists exacerbations costs
Online Access:	https://www.mdpi.com/1424-8247/16/11/1609

Similar Items

Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study
by: Choi KY, et al.
Published: (2024-07-01)

Single inhaler with beclometasone, formoterol, and glycopyrronium versus triple therapies in adults with uncontrolled asthma: a systematic review and meta-analysis
by: Fulvio Braido, et al.
Published: (2025-02-01)

AM/PM dosing of LAMA for COPD: a randomized controlled trial protocol using digital recruitment and registries
by: Pradeesh Sivapalan, et al.
Published: (2024-08-01)

Run-in periods and treatment outcomes in asthma trials: A narrative review
by: Emilio Pizzichini, et al.
Published: (2024-12-01)

The effect of combining an inhaled corticosteroid and a long-acting muscarinic antagonist on human airway epithelial cells in vitro
by: Maria Gabriella Matera, et al.
Published: (2024-02-01)

Therapeutic effect of long-acting muscarinic antagonist for treating uncontrolled asthma assessed using impulse oscillometry
by: Hiroyuki Sugawara, et al.
Published: (2024-08-01)

Episodes of asthma during pregnancy – link with a viral infection and treatment approaches
by: Pertseva T.A., et al.
Published: (2014-06-01)

Probiotics in Children with Asthma
by: Giorgio Ciprandi, et al.
Published: (2022-06-01)

Comparative cardiovascular safety of LABA/LAMA FDC versus LABA/ICS FDC in patients with chronic obstructive pulmonary disease: a population-based cohort study with a target trial emulation framework
by: Chun-Yu Chen, et al.
Published: (2023-09-01)

Real-World Disease Burden and Healthcare Resource Utilization Among Patients with COPD and Asthma Using Triple Therapy (FF/UMEC/VI) in the United States
by: Igboekwe E, et al.
Published: (2024-01-01)

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study
by: Jutta Beier, et al.
Published: (2013-08-01)

Patterns of bronchodilator therapy in asthmatic outpatients
by: Toetik Aryani, et al.
Published: (2023-03-01)

ReCOMmendations for management of Preschool ASthma for General Practitioners – COMPAS GP
by: Zbigniew Doniec, et al.
Published: (2016-06-01)

Management of chronic obstructive pulmonary disease: Insights into patient profile – Use of inhaled corticosteroids/long-acting β2-Agonists or long-acting β2-agonists/long-acting muscarinic antagonists
by: Nevin Kishore, et al.
Published: (2020-01-01)

Triple Therapy with Mometasone/Indacaterol/Glycopyrronium or Doubling the ICS/LABA Dose in GINA Step 4: IRIDIUM Analyses
by: Richard N. van Zyl-Smit, et al.
Published: (2023-08-01)

Long-acting Bronchodilators in COPD Management: One or Two?
by: Konstantinos Kostikas, et al.
Published: (2023-01-01)

Evaluation of adherence to guideline-directed therapy and risk factors for exacerbation in mild asthma: a retrospective chart review
by: Beth A. Zerr, et al.
Published: (2024-03-01)

Management of Asthma and COPD Exacerbations in Adults in the ICUKey PointsClinical QuestionClinical Question
by: Stephen A. Mein, MD, et al.
Published: (2025-03-01)

Clinical outcomes of children with acute asthma managed with intravenous magnesium sulphate outside intensive care setting
by: Danish Abdul Aziz, et al.
Published: (2023-09-01)

Global Initiative for Asthma (GINA) guideline: achieving optimal asthma control in children aged 6-11 years
by: Danish Abdul Aziz, et al.
Published: (2023-09-01)

Ketamine for Adults with Severe Asthma Exacerbation: A Systematic Review and Meta-analysis
by: Fatimah AlShehri, et al.
Published: (2022-01-01)

Inhaled magnesium versus inhaled salbutamol in rescue treatment for moderate and severe asthma exacerbations in pediatric patients
by: Michelle Siqueira Debiazzi, et al.
Published: (2024-09-01)

Virus-induced asthma exacerbations in Vietnamese preschoolers
by: Nguyen Thuy Van Thao, et al.
Published: (2025-03-01)

Evaluation of Asthma Course in Patients Hospitalized in Pediatric Intensive Care Unit Due to Severe Asthma Exacerbation
by: Ahmet Selmanoglu, et al.
Published: (2025-02-01)

Socioeconomic status, diet, and recurrent severe asthma exacerbations in Puerto Rican youth
by: Kristina Gaietto, MD MPH, et al.
Published: (2024-05-01)

Benralizumab: Effectiveness in Patients with Uncontrolled Severe Eosinophilic Asthma at 6 and 12 Months at a Third-Level Care Hospital. Capacity for ICS-LABA Therapy Reduction
by: González-Tuyub YH, et al.
Published: (2024-11-01)

Editorial: Microbiota and asthma
by: Brandon Bautista-Becerril, et al.
Published: (2023-11-01)

Benefit of dual bronchodilator therapy on exacerbations in former and current smokers with chronic obstructive pulmonary disease in real-world clinical practice: a multicenter validation study (TOReTO)
by: Yu-Ting Lai, et al.
Published: (2024-10-01)

Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States
by: Bogart M, et al.
Published: (2024-01-01)

Antiviral roles of eosinophils in asthma and respiratory viral infection
by: Hisashi Sasaki, et al.
Published: (2025-02-01)

Role of stimulating combined visceral meridians by laser acupuncture on asthma exacerbation and quality of life of asthmatic patients
by: Asmaa A. A. Al Sharkawy, et al.
Published: (2024-12-01)

The Importance of Spirometry in Bronchial Asthma Management and the Predictive Value of FEV1 and MMEF Parameters for Future Exacerbations
by: Ioana MARICA, et al.
Published: (2024-05-01)

Epidemiology and Immunopathogenesis of Virus Associated Asthma Exacerbations
by: Bakakos A, et al.
Published: (2023-09-01)

Case of uncontrolled asthma with Ceriporia lacerata-related broncholithiasis
by: Chihiro Nakano, et al.
Published: (2023-01-01)

Characterization of Serum Cytokine Patterns in Frequent-Exacerbation Asthma: Implications for Phenotyping and Management
by: Dao Ngoc Bang, et al.
Published: (2024-12-01)

A survey study on antibiotic prescription practices for acute asthma exacerbations: An European academy of allergy and clinical immunology task force report
by: Anne‐Lotte Redel, et al.
Published: (2024-03-01)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study [Corrigendum]
by: Strange C, et al.
Published: (2024-08-01)

Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study
by: Strange C, et al.
Published: (2023-10-01)

Study the relationship between serum lipid profile and bronchial asthma exacerbation
by: Israa S.M.M. Elkordi, et al.
Published: (2024-04-01)

A Delphi Consensus Project to Capture Greek Experts’ Opinion on the Position of Triple Therapies in COPD: Why, When and to Whom
by: Papaioannou AI, et al.
Published: (2025-02-01)